Table 1. Baseline characteristics of the subjects.
| Characteristic | DA-9701 group (n = 18) | Placebo group (n = 19) | P-value* |
|---|---|---|---|
| Age, years | 0.280 | ||
| Mean ± SD | 32.8 ± 7.6 | 35.8 ± 9.3 | |
| Median (range) | 30.5 (22.0–48.0) | 35.0 (23.0–56.0) | |
| Sex, n (%) | 1.000 | ||
| Male | 9 (50.0) | 9 (47.4) | |
| Female | 9 (50.0) | 10 (52.6) | |
| Height, cm | 0.658 | ||
| Mean ± SD | 166.8 ± 8.0 | 168.0 ± 8.6 | |
| Median (range) | 166.1 (155.7–184.4) | 166.0 (153.1–184.4) | |
| Weight, kg | 0.935 | ||
| Mean ± SD | 65.9 ± 12.4 | 65.6 ± 15.1 | |
| Median (range) | 64.3 (48.7–89.5) | 63.9 (43.1–91.7) | |
| Body mass index, kg/m 2 | 0.581 | ||
| Mean ± SD | 23.6 ± 3.1 | 22.9 ± 3.5 | |
| Median (range) | 23.0 (19.9–30.0) | 22.5 (17.1–28.5) |
* Fisher’s exact test for sex variable between DA-9701 and placebo groups and 2-sample t-test for continuous variables between DA-9701 and placebo groups after normality checking (P > 0.05)